Open Access Journal of Pharmaceutical Research (OAJPR)

ISSN: 2574-7797

Review Article

Lercanidipine Over Other Calcium Channel Blocker in Elderly Patients & its Renal Protection in Future

Authors: Darshan SS*, Rutika BW, Piyush VB, Khemchand RS, Chandrashekhar DP and Dhananajay MP

DOI: 10.23880/oajpr-16000296

Abstract

A calcium channel blocker called lercanidipine shows promise as a treatment for hypertension, especially in older people. Exhibiting greater effectiveness in comparison to other calcium channel blockers, it presents encouraging opportunities for the management of hypertension. Its use has a low risk to renal function, which sets it apart from other medicines in its class that might have a negative impact on the kidneys. Consequently, lercanidipine distinguishes itself as a beneficial and well-tolerated treatment choice for hypertension patients, providing a possible way to address cardiovascular issues without jeopardizing renal function, particularly in the elderly population.

Keywords: Lercanidipine; Hypertension; Calcium channel blocker; Renal Protection

View PDF

F1 europub scilit.net

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?